N4 Pharma Plc Share News (N4P)

N4 Pharma Plc Information

Buy N4P Shares
Add N4P to Watchlist
Add N4P to Alert

Share Price Information for N4 Pharma Plc (N4P)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 0.625

Bid: 0.60

Ask: 0.65

Change: -0.025 (-3.85%)

Spread: 0.05 (8.333%)

Open: 0.65

High: 0.65

Low: 0.625

Prev. Close: 0.65

Last checked at -

UK Shareholder Meetings Calendar - Next 7 Days

Thu, 16th Apr 2020 15:59

Friday 17 April

Herald Investment Trust

Monday 20 April

MetalNRG

SThree

Tuesday 21 April

Porvair

London Stock Exchange

SEGRO

GlobalData

Wednesday 22 April

Drax Group

Premier Global Infrastructure Trust

Glanbia

Arkle Resources (re share capital reorganisation)

Thursday 23 April

RELX

CRH

Alumasc Group (re capital reorganisation)

N4 Pharma

AFC Energy

CLS Holdings

Aggreko

Croda

Blencowe Resources (re reverse takeover)

Meggitt

Taylor Wimpey

Tullow Oil

Alliance Trust

More News

25 Mar 2020 12:15

N4 Pharma Explores Nuvec's Potential In Covid-19 Vaccine Delivery

24 Mar 2020 15:49

UK Shareholder Meetings Calendar - Next 7 Days

25 Feb 2020 11:42

N4 Pharma Annual Loss Narrows Amid Work To Improve Nuvec System

25 Feb 2020 08:49

N4 Pharma narrows loss as it continues development work

(Sharecast News) - Specialist pharmaceutical company N4 Pharma reported a smaller operating loss for 2019 on Tuesday, at ?0.95m, compared to ?1.42m in the prior year.

11 Feb 2020 14:19

N4 Pharma shares rise on partnership with Nanomerics

(Sharecast News) - Specialist pharmaceutical company N4 Pharma has signed a 14-month research collaboration with Nanomerics to produce and test two candidate formulations using its 'Nuvec' delivery system, it announced on Tuesday.

11 Feb 2020 11:37

N4 Pharma Signs Research Collaboration Agreement With Nanomerics

18 Sep 2019 12:04

N4 Pharma Interim Loss Widens After Non-Repeat Of Grant, Disposal Gain

(Alliance News) - N4 Pharma PLC on Wednesday said its loss widened slightly in the first half of the year, owing to grant income and a gain on an investment sale the year before which did not in a

20 Aug 2019 11:49

N4 Pharma Repeats Study And Finds Nuvec Successful At "Certain Doses"

(Alliance News) - N4 Pharma PLC on Tuesday said it has repeated the in-vivo study of Nuvec and shown it does work "when using multiple injections at certain doses".Shares in N4 at

19 Jun 2019 13:38

N4 Pharma To Start Experiments On Nuvec; Results Due In Two Months

(Alliance News) - N4 Pharma PLC on Wednesday said it will begin experiments on its Nuvec system on Friday this week with results due in around two months.Shares in N4 were up 20% at 4.30 in

12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

14 May 2019 12:09

N4 Pharma Loss Narrowed By Cost; Will Explore Assets Outside Nuvec

LONDON (Alliance News) - N4 Pharma PLC on Tuesday reported a narrowed loss for 2018 on lower costs and said it is exploring new opportunities while continuing work on core Nuvec drug delivery in -

15 Apr 2019 15:33

N4 Pharma reassures shareholders over future of 'Nuvec'

(Sharecast News) - Specialist pharmaceutical company N4 Pharma updated the market on the development of 'Nuvec' on Monday, following the disclosure of inconsistencies in the efficacy of Nuvec between various in vitro and in vivo studies.

15 Apr 2019 15:20

N4 Pharma Finds Issues With In Vivo Nuvec Testing And Plans Repeat

LONDON (Alliance News) - N4 Pharma PLC on Monday said it has become aware of a number of issues with the in vivo studies of its Nuvec delivery system.On Tuesday last week, N4 announced of a

9 Apr 2019 11:27

N4 Pharma Shares Sink As Nuvec Fails To Produce Response In-Vivo

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said early in-vivo tests of its Nuvec delivery system did not match positive results from in-vitro tests, causing shares to slump.Shares in

Latest Share Chat

N4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account